Exploring the highs and lows of IOLs during 2007.
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
Vision- and life-threatening neuro-ophthalmological presentations
Paediatric diagnoses of juvenile idiopathic intracranial hypertension, optic neuritis and Horner syndrome
PHOTON Results and Their Relation to DME Patients in Your Practice
John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.
ENTOD Pharmaceuticals announces CDSCO approval of 0.05% atropine drops (Myatro XL)
According to a press release, Myatro XL is the first 0.05% atropine eye drop for paediatric myopia control.
PULSAR Results and Their Relation to nAMD Patients in Your Practice
John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.
Neurotech appoints Beth Marsh as chief commercial officer ahead of US product launch
The US FDA recently approved revakinagene taroretcel-lwey (ENCELTO) for the treatment of idiopathic macular telangiectasia type 2 (MacTel)
New trends in the diagnosis of dry eye disease: A patient-centric approach
A five-step approach to personalise and simplify treatment, leading to higher efficacy